Together Rx Access gears up to launch new ad campaign

Share this article:
The Together Rx Access advertising campaign will launch April 25 with the tagline, "Take care of your health."
The program, designed to help low-income individuals and families receive Rx drug coverage, will run a "pulsed" promotional campaign, said executive director Roba Whiteley, beginning with ads on 12 cable networks and phasing in radio in 34 markets, with a focus on areas with high concentrations of the uninsured, African Americans and Hispanics.
Viewers will be directed to the Web site, togetherrxaccess.com, or a 24-hour call center through a toll-free number. A freestanding insert, including an enrollment form, will appear in Sunday newspapers.
Together Rx has piloted regional media events in Los Angeles and Miami, and is honing its grassroots campaign in Texas, where outreach efforts have targeted convenience stores and Head Start programs as well as pharmacies and physicians' offices.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...